Skip to main content

Want a detailed portfolio tracker?

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) Free Cash Flow (2019 - 2026)

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) free cash flow from Sep 30, 2019 to Mar 31, 2026. The TTM Coeptis Therapeutics Holdings Inc. Common Stock (COEP) free cash flow is -$8M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM+40.85%
5 Years TTM+124.59%

Annual Free Cash Flow change of Coeptis Therapeutics Holdings Inc. Common Stock (COEP)

YearFree Cash FlowChange
2026-$1.76M-79.53%
2025-$8.60M+29.32%
2024-$6.65M-8.15%
2023-$7.24M+86.60%
2022-$3.88M+676.00%
2021-$500K+316.67%
2020-$120KN/A
2019$0N/A